Clinical trial
COMPASS: A Novel Transition Program to Reduce Disability After Stroke
NCT03485820 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- COMPASS: A Novel Transition Program to Reduce Disability After Stroke
- Lead sponsor
- Washington University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 9, 2018
- Completion date
- February 28, 2024
- Enrollment
- 185 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.